{"SPADE_UN_16273": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_16273", "Peptide Name": "Helical1", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "FLWIKLGKLAGAVLKLILGLKKVV", "Sequence Length": 24, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:MCF-7  (EC50=4.4 ± 1.3 µM ); A549 (EC50=8.3 ± 2.0 µM)", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C131H226N30O25", "Mass": 2621.38, "PI": 10.6, "Net Charge": 5, "Hydrophobicity": 1.38, "Half Life": "Mammalian:1.1 hourYeast:3 minE.coli:2 min", "Literature": [{"Title": "In silico design and optimization of selective membranolytic anticancer peptides", "Pubmed ID": "31375699", "Reference": "Sci Rep. 2019 Aug 2;9(1)11282.", "Author": "Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=31375699"}], "Frequent Amino Acids": "LKG", "Absent Amino Acids": "CDEHMNOPQRSTUY", "Basic Residues": 5, "Acidic Residues": 0, "Hydrophobic Residues": 16, "Polar Residues": 10, "Positive Residues": 5, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_16328", "Similarity": 0.8333333333333334, "Sequence": "GLKKVIKLLRPLL"}, {"SPADE_ID": "SPADE_UN_16384", "Similarity": 0.8, "Sequence": "LKKVLKAAAKAALNAVLVGANA"}, {"SPADE_ID": "SPADE_UN_22983", "Similarity": 0.7, "Sequence": "KLLKLLKKVVGALG"}]}}}